Jim Cramer Says These Stocks ‘Nothing There’
June 10, 2024
Dollar General Corp (NYSE:DG) on Thursday reported better-than-expected second-quarter financial results and raised its FY26 guidance above estimates. The discount retailer reported net sales of $11.29 billion, up 5.2% year over year. Revenue beat the consensus estimate of $11.197 billion. Earnings rose 33% to $2.48 per share, beating the Street estimate of $2.01. The result […]
Avi Kapoor | August 28, 2026
Shares of Moderna Inc. (NASDAQ:MRNA) are trading slightly lower Wednesday morning, taking a brief pause after surging more than 150% following landmark clinical trial updates for its oncology pipeline. The modest retreat reflects routine profit-taking and consolidation as investors digest the recent momentum. Moderna stock is among today’s weakest performers. Why is MRNA stock falling? […]
Henry Khederian | August 26, 2026
Anthropic’s reported potential $2 trillion valuation would require investors to underwrite an extraordinary combination of growth and margin expansion, while also taking lessons from Space Exploration Technologies Corp.‘s (NASDAQ:SPCX) turbulent transition from private-market darling to public company, says Dr Chan Ahn, founder and CEO of Tessera PE and a former Goldman Sachs and JPMorgan executive. […]
Namrata Sen | August 23, 2026
Quantitative investment firm Starkiller Capital on Friday declared that the crypto cycle has bottomed, calling Bitcoin and Ethereum the clearest end-of-cycle setup it has seen. Why Starkiller Says the Cycle Has Turned? Starkiller Capital wrote in a research note that both Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) are back above their 200-day moving averages […]
Parshwa Turakhiya | August 21, 2026
Shares of Tempus AI Inc (NASDAQ:TEM) are surging Wednesday morning as traders connected the dots between a landmark clinical trial win and Tempus’s recent multi-billion dollar acquisition deal. Here’s what investors need to know. Tempus AI stock is surging to new heights today. What’s behind TEM gains? Landmark mRNA Trial Delivers Breakthrough Results The rally […]
Henry Khederian | August 19, 2026
June 10, 2024
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |